Cambridge Health Group, a subsidiary of Amanat Holdings PJSC, appointed Wael Abdallah as Chief Executive Officer, effective March 12, 2026.
Mr. Abdallah previously served as the group's Interim CEO since February 2025 and was formerly the Chief Investment Officer.
The group reported record 2025 financial results with revenue of AED 404 million (up 11% year-on-year) and EBITDA of AED 100 million (up 14% year-on-year).
Operational capacity is expected to expand from 625 beds at the end of 2025 to approximately 725 beds in 2026, targeting a long-term goal of over 1,000 post-acute care beds.